As of 2026-09-17, the Relative Valuation of Neogenomics Inc (NEO) is (12.49) USD. This relative valuation is based on P/E multiples. With the latest stock price at 18.94 USD, the upside of Neogenomics Inc based on Relative Valuation is -165.9%.
The range of the Relative Valuation is (12.78) - (11.66) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 31.6x - 34.8x | 33.4x |
| Forward P/E multiples | 28.3x - 28.9x | 28.4x |
| Fair Price | (12.78) - (11.66) | (12.49) |
| Upside | -167.5% - -161.6% | -165.9% |
| Date | P/E |
| 2026-09-16 | -46.91 |
| 2026-09-15 | -46.78 |
| 2026-09-14 | -45.59 |
| 2026-09-11 | -42.89 |
| 2026-09-10 | -43.61 |
| 2026-09-09 | -43.74 |
| 2026-09-08 | -43.49 |
| 2026-09-04 | -43.04 |
| 2026-09-03 | -43.24 |
| 2026-09-02 | -43.09 |
| 2026-09-01 | -43.22 |
| 2026-08-31 | -44.36 |
| 2026-08-28 | -44.70 |
| 2026-08-27 | -46.16 |
| 2026-08-26 | -43.02 |
| 2026-08-25 | -41.58 |
| 2026-08-24 | -40.64 |
| 2026-08-21 | -42.05 |
| 2026-08-20 | -40.94 |
| 2026-08-19 | -41.25 |
| 2026-08-18 | -39.38 |
| 2026-08-17 | -40.02 |
| 2026-08-14 | -39.48 |
| 2026-08-13 | -40.59 |
| 2026-08-12 | -40.67 |
| 2026-08-11 | -40.94 |
| 2026-08-10 | -41.19 |
| 2026-08-07 | -41.04 |
| 2026-08-06 | -38.54 |
| 2026-08-05 | -38.96 |
| 2026-08-04 | -40.34 |
| 2026-08-03 | -39.23 |
| 2026-07-31 | -37.87 |
| 2026-07-30 | -39.33 |
| 2026-07-29 | -37.82 |
| 2026-07-28 | -33.19 |
| 2026-07-27 | -32.54 |
| 2026-07-24 | -34.40 |
| 2026-07-23 | -35.27 |
| 2026-07-22 | -34.70 |
| 2026-07-21 | -35.79 |
| 2026-07-20 | -35.27 |
| 2026-07-17 | -36.18 |
| 2026-07-16 | -36.75 |
| 2026-07-15 | -35.91 |
| 2026-07-14 | -35.24 |
| 2026-07-13 | -34.94 |
| 2026-07-10 | -34.94 |
| 2026-07-09 | -36.48 |
| 2026-07-08 | -35.27 |